Lahore (Muhammad Yasir) Getz Pharma, on behalf of South Asian Federation of Endocrine Societies (SAFES) & South Asian Federation of Obstetrics and Gynaecology (SAFOG), held a launch meeting of Gestational Diabetes Mellitus (GDM) guidelines.
Eminent endocrinologists, gynecologists and dignitaries were invited at the launch ceremony to talk about the first ever guidelines for the management of GDM for the South Asian region. These guidelines were developed by SAFES in collaboration with SAFOG.
Key attendees of the event included Dr. Abbas Raza – President – SAFES (South Asian Federation of Endocrine Societies); Dr. Rubina Sohail – President – SAFOG (South Asian Federation of Obstetrics and Gynaecology); Dr. Ali Jawa – President – PES (Pakistan Endocrine Society); Dr. Faisal Masood Qureshi – Vice President – American College of Clinical Endocrinology – Pakistan Chapter; Dr. Khursheed A Khan – Head of Department – Allama Iqbal Medical College/Jinnah hospital; Dr. Fawad Randhawa – Vice President Punjab – PES – Pakistan Endocrine Society; Dr. Aisha Sheikh – Vice President Sindh – PES – Pakistan Endocrine Society; Dr. Bilal Bin Younus – Head of Department – SiDER -Shalamar Institute of Health Sciences; Dr. Noman Uddin – Director Business Unit Cardio metabolic Division – Getz Pharma; Dr. Nadia Hussain – Ambassador for the cause of Women & Diabetes / Model / Actor / Entrepreneur & Fashion Designer and Ms. Uzma Manzar – Chief Executive Platform / Chairperson Standing Committee LCCI / Director Hamara Pakistan Trust who spoke to the media on the occasion.
GDM is associated with serious complications and may cause adverse foetal outcomes, “Despite the fact that challenge of diabetes and endocrine disorders looms large in our society, there are still millions of diabetic patients who are denied the benefits of Diabetic care and no set form of research or guidelines are present which specifically caters the need of the region,” said Dr. Abbas Raza, additionally sharing his vision to elevate the diabetic care standards in South Asia to be at par with developed countries.
“Getz Pharma is the first and only pharmaceutical company in Pakistan with a manufacturing facility pre-qualified by World Health Organization (WHO) and certified for Good Manufacturing Practices by Pharmaceutical Inspection Cooperation Scheme (PIC/S). These accreditations speaks of our commitment to the patients’ health and quality of life,” said Dr. Noman Uddin, adding, “Our collaboration with SAFES to disseminate these guidelines throughout the Pakistani healthcare community shows our commitment and passion to promoting better management of diabetes.”
South Asian Federation of Endocrine Societies (SAFES) & South Asian Federation of Obstetrics and Gynaecology (SAFOG) is an association of international professional bodies in South Asia, societies of Bangladesh, India, Nepal, Pakistan, Sri Lanka and Maldives to focus and support region-specific issues of Endocrinology, Diabetes, Metabolic disorders, Obstetrics and Gynaecology.
Both independent authorities have joined hands to conduct extensive research on GDM and have agreed to minimize this disease situation with various social and educational initiatives in collaboration with philanthropic organizations and institutions like Getz Pharma.
The advisory board lauded the efforts of Getz Pharma for highlighting the cause and discussed the next action steps.
